항기생충제 시장 규모는 향후 몇 년동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 6.9%의 연평균 복합 성장률(CAGR)로 336억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 새로운 기생충 위협, 기후 변화, 매개체 질환, 세계 보건 안보에 대한 관심 증가, 의료 서비스 접근성 향상에 기인합니다. 예측 기간의 주요 동향으로는 약물 개발의 발전, 표적 치료, 병용 요법, 민관 파트너십, 원격 의료, 원격 진단 등이 있습니다.
매개체 질환의 발생률 증가는 항기생충제 시장의 성장을 크게 견인할 것으로 예상됩니다. 모기, 진드기, 파리 등의 곤충에 물려 사람에게 감염되는 매개체 질환에는 말라리아, 뎅기열, 황열병 등의 질병이 포함됩니다. 항기생충제는 이러한 질병을 유발하는 기생충을 퇴치하고 통제하는 데 중요한 역할을 하며, 질병의 확산을 억제하고 공중보건에 미치는 영향을 줄이는 데 도움이 됩니다. 예를 들어, 클로로퀸, 독시사이클린, 아토바콘 프로가닐 등의 약품은 말라리아 치료에 일반적으로 사용됩니다. 미국 질병예방통제센터(CDC)에 따르면, 2024년 6월에는 북미와 남미에서 970만 명 이상의 뎅기열 환자가 보고되어 2023년 460만 명보다 2배 이상 증가한 것으로 나타났습니다. 미국에서는 푸에르토리코에서만 1,498명의 뎅기열 환자가 보고되었으며, 이 중 745명은 감염지역에서 귀국한 여행객이었습니다. 이러한 매개체 질환 증가는 효과적인 항기생충 치료에 대한 심각한 요구를 명확히 하고, 항기생충제 시장의 성장을 더욱 촉진할 것입니다.
기생충 감염의 높은 유병률은 항기생충제 시장의 성장을 크게 견인할 것으로 예상됩니다. 원충, 촌충, 회충, 리케치아 등의 기생충 감염은 심각한 건강 위협을 초래하고 경미한 증상부터 생명을 위협하는 심각한 질병까지 다양한 증상을 유발할 수 있습니다. 항기생충제는 이러한 감염증의 치료에 필수적이며, 증상 완화, 합병증 예방, 전반적인 건강 상태 개선에 도움이 됩니다. 영국 정부의 2024년 5월 보고서에 따르면, 2022년 잉글랜드와 웨일즈에서 31건의 리케치아 감염이 보고되어 기생충 감염이 얼마나 강력한지 알 수 있습니다. 전 세계적으로 기생충 질환의 관리 문제가 대두되고 있는 가운데, 효과적인 항기생충 치료제에 대한 수요는 지속적으로 증가하여 시장을 더욱 견인할 것으로 예상됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나19와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 항기생충제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
- 최종 이용 산업 분석
- 세계의 항기생충제 시장 : 성장률 분석
- 세계의 항기생충제 시장 실적 : 규모와 성장, 2019-2024
- 세계의 항기생충제 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계항기생충제 전체 시장(TAM)
제6장 시장 세분화
- 세계의 항기생충제 시장 : 제품 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 구충약
- 항원충
- 외부 구충제
- 세계의 항기생충제 시장 : 치료별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- Avermectins
- Bezimidazoles
- Pyrimidines
- Organophosphates
- Imidazolesthiazoles
- 세계의 항기생충제 시장 : 투여 경로별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 경구
- 주사
- 국소
- 세계의 항기생충제 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 홈케어
- 전문 클리닉
- 기타 최종사용자
- 세계의 항기생충제 시장 : 구충약 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- Benzimidazoles
- Ivermectin
- Pyrantel Pamoate
- Praziquantel
- 세계의 항기생충제 시장 : 항원충별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- Metronidazole
- Tinidazole
- Nitazoxanide
- Pentamidine
- 세계의 항기생충제 시장 : 외부 구충제 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- Permethrin
- Malathion
- Lindane
- Fipronil
- 세계의 항기생충제 시장 : 기타 제품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 복합 항기생충제
- 신규 항기생충제
제7장 지역별/국가별 분석
- 세계의 항기생충제 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 항기생충제 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 항기생충제시장 : 경쟁 구도
- 항기생충제시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- Cadila Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
- Merck & Co.Inc. Overview, Products and Services, Strategy and Financial Analysis
- Bayer AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- Novartis AG
- Sanofi S.A.
- GlaxoSmithKline plc
- Takeda Pharmaceutical Company Limited
- Boehringer Ingelheim group
- Zoetis Inc.
- Eisai Co. Ltd.
- Covetrus Inc.
- IDEXX Laboratories Inc.
- Dr. Reddy's Laboratories
- Intas Pharmaceuticals Ltd
- Alkem Laboratories Ltd
- Ceva Sante Animale S.A.
- Elanco Animal Health Incorporated
- Phibro Animal Health Corporation
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 항기생충제시장(2029년) : 새로운 기회를 제공하는 국가
- 항기생충제시장(2029년) : 새로운 기회를 제공하는 부문
- 항기생충제시장(2029년) : 성장 전략
제36장 부록
LSH
Antiparasitic drugs encompass a category of medications designed to combat infections triggered by a variety of parasites that have the potential to infest humans, animals, or plants. Parasites are living organisms that either reside on or within a host organism, drawing sustenance from it and often causing harm in the process. Antiparasitic drugs are formulated to specifically target these parasites, either by exterminating them or inhibiting their growth.
The primary product categories within antiparasitic drugs include anthelmintics, antiprotozoals, ectoparasiticides, and other related treatments. Anthelmintics, for instance, are a class of drugs tailored to address infections caused by parasitic worms. They operate by either eradicating the parasites or stunting their growth and reproductive capabilities. A diverse range of treatments falls under this category, including avermectins, benzimidazoles, pyrimidines, organophosphates, and imidazole thiazoles. These treatments can be administered through various means, such as orally, through injections, or topically, and are employed across a spectrum of end-users, including hospitals, homecare settings, specialty clinics, and others.
The antiparasitic drugs market research report is one of a series of new reports from The Business Research Company that provides antiparasitic drugs market statistics, including antiparasitic drugs industry global market size, regional shares, competitors with an antiparasitic drugs market share, detailed antiparasitic drugs market segments, market trends and opportunities and any further data you may need to thrive in the antiparasitic drugs industry. This antiparasitic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The antiparasitic drugs market size has grown strongly in recent years. It will grow from $24.06 billion in 2024 to $25.75 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to prevalence of parasitic infections, resistance to existing treatments, global health initiatives,.
The antiparasitic drugs market size is expected to see strong growth in the next few years. It will grow to $33.64 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to emerging parasitic threats, climate change and vector-borne diseases, increased emphasis on global health security, access to healthcare. Major trends in the forecast period include advances in drug development, targeted therapies, combination therapies, public-private partnerships, telemedicine and remote diagnosis.
The increasing incidence of vector-borne diseases is expected to significantly drive the growth of the antiparasitic drugs market. Vector-borne diseases, which are transmitted to humans through the bites of insects such as mosquitoes, ticks, and flies, include conditions like malaria, dengue, and yellow fever. Antiparasitic drugs play a vital role in controlling and eliminating the parasites responsible for these diseases, helping to reduce their spread and impact on public health. For example, drugs like chloroquine, doxycycline, and atovaquone-proguanil are commonly used to treat malaria. According to the Centers for Disease Control and Prevention (CDC), in June 2024, over 9.7 million dengue cases were reported across the Americas, more than double the 4.6 million cases in 2023. In the U.S., Puerto Rico alone reported 1,498 dengue cases, with 745 cases among travelers returning from affected areas. This rise in vector-borne diseases underlines the critical need for effective antiparasitic treatments, further driving the growth of the antiparasitic drugs market.
The high prevalence of parasitic infections is expected to significantly drive the growth of the antiparasitic drug market. Parasitic infections, caused by organisms such as protozoa, worms, and rickettsia, pose a serious health threat and can lead to conditions ranging from mild illness to severe, life-threatening diseases. Antiparasitic drugs are crucial for treating these infections, helping to alleviate symptoms, prevent complications, and improve overall health outcomes. According to a May 2024 report by Gov. UK, in 2022, 31 rickettsial infection cases were reported in England and Wales, highlighting the persistence of parasitic infections. With ongoing challenges in managing parasitic diseases globally, the demand for effective antiparasitic treatments is expected to continue growing, further propelling the market.
Major companies operating in the antiparasitic drugs market are increasingly focusing on the development of innovative products, such as chewable veterinary medications, to improve ease of administration and enhance pet compliance. These chewable products are typically flavored, making them more appealing to pets and reducing the stress often associated with administering medications. For example, in April 2024, C.H. Boehringer Sohn AG & Co. KG, a Germany-based pharmaceutical company, launched NexGard Spectra. This soft, flavorful chew provides comprehensive parasite control for dogs, targeting fleas, ticks, heartworms, and various intestinal worms. NexGard Spectra is a highly effective treatment, killing fleas within four hours of administration and offering over 99% effectiveness against multiple parasites with a single monthly dose, further enhancing convenience and compliance for pet owners.
In June 2022, Orion Corporation, a pharmaceutical company headquartered in Finland, completed the acquisition of Inovet BV's animal health division for $141 million (€130 million). This strategic acquisition is anticipated to bolster Orion Corporation's presence in Western Europe and export markets, and it will also grant them access to a dedicated production facility specializing in the manufacturing of veterinary medicines. Inovet BV, based in Belgium, is a renowned veterinary pharmaceutical company known for its wide range of products, including antiparasitic treatments, antibiotics, and vaccines.
Major companies operating in the antiparasitic drugs market are Pfizer Inc., Johnson & Johnson, Cadila Pharmaceuticals, Merck & Co.Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim group, Zoetis Inc., Eisai Co. Ltd., Covetrus Inc., IDEXX Laboratories Inc., Dr. Reddy's Laboratories, Intas Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ceva Sante Animale S.A., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Mankind Pharma, Neogen Corporation, Bimeda Inc., Indoco Remedies Ltd., ECO Animal Health, Lincoln Pharmaceuticals Ltd., Laboratorios Calier.
North America was the largest region in the antiparasitic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antiparasitic drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the antiparasitic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The antiparasitic drugs market consists of sales of antimalarial drugs, antiamoebic drugs, anti-trematode drugs and veterinary products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Antiparasitic Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on antiparasitic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for antiparasitic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antiparasitic drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product Type: Anthelmintics; Antiprotozoals; Ectoparasiticide; Other Products
- 2) By Treatment: Avermectins; Bezimidazoles; Pyrimidines; Organophosphates; Imidazolesthiazoles
- 3) By Route of Administration: Oral; Injectable; Topical
- 4) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
- Subsegments:
- 1) By Anthelmintics: Benzimidazoles; Ivermectin; Pyrantel Pamoate; Praziquantel
- 2) By Antiprotozoals: Metronidazole; Tinidazole; Nitazoxanide; Pentamidine
- 3) By Ectoparasiticides: Permethrin; Malathion; Lindane; Fipronil
- 4) By Other Products: Combination Antiparasitic Drugs; Novel Antiparasitic Agents
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Cadila Pharmaceuticals; Merck & Co.Inc.; Bayer AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Antiparasitic Drugs Market Characteristics
3. Antiparasitic Drugs Market Trends And Strategies
4. Antiparasitic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Antiparasitic Drugs Growth Analysis And Strategic Analysis Framework
- 5.1. Global Antiparasitic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Antiparasitic Drugs Market Growth Rate Analysis
- 5.4. Global Antiparasitic Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Antiparasitic Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Antiparasitic Drugs Total Addressable Market (TAM)
6. Antiparasitic Drugs Market Segmentation
- 6.1. Global Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Anthelmintics
- Antiprotozoals
- Ectoparasiticide
- 6.2. Global Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Avermectins
- Bezimidazoles
- Pyrimidines
- Organophosphates
- Imidazolesthiazoles
- 6.3. Global Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Injectable
- Topical
- 6.4. Global Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Homecare
- Specialty Clinics
- Other End Users
- 6.5. Global Antiparasitic Drugs Market, Sub-Segmentation Of Anthelmintics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Benzimidazoles
- Ivermectin
- Pyrantel Pamoate
- Praziquantel
- 6.6. Global Antiparasitic Drugs Market, Sub-Segmentation Of Antiprotozoals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Metronidazole
- Tinidazole
- Nitazoxanide
- Pentamidine
- 6.7. Global Antiparasitic Drugs Market, Sub-Segmentation Of Ectoparasiticides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Permethrin
- Malathion
- Lindane
- Fipronil
- 6.8. Global Antiparasitic Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Combination Antiparasitic Drugs
- Novel Antiparasitic Agents
7. Antiparasitic Drugs Market Regional And Country Analysis
- 7.1. Global Antiparasitic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Antiparasitic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Antiparasitic Drugs Market
- 8.1. Asia-Pacific Antiparasitic Drugs Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Antiparasitic Drugs Market
- 9.1. China Antiparasitic Drugs Market Overview
- 9.2. China Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Antiparasitic Drugs Market
- 10.1. India Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Antiparasitic Drugs Market
- 11.1. Japan Antiparasitic Drugs Market Overview
- 11.2. Japan Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Antiparasitic Drugs Market
- 12.1. Australia Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Antiparasitic Drugs Market
- 13.1. Indonesia Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Antiparasitic Drugs Market
- 14.1. South Korea Antiparasitic Drugs Market Overview
- 14.2. South Korea Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Antiparasitic Drugs Market
- 15.1. Western Europe Antiparasitic Drugs Market Overview
- 15.2. Western Europe Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Antiparasitic Drugs Market
- 16.1. UK Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Antiparasitic Drugs Market
- 17.1. Germany Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Antiparasitic Drugs Market
- 18.1. France Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Antiparasitic Drugs Market
- 19.1. Italy Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Antiparasitic Drugs Market
- 20.1. Spain Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Antiparasitic Drugs Market
- 21.1. Eastern Europe Antiparasitic Drugs Market Overview
- 21.2. Eastern Europe Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Antiparasitic Drugs Market
- 22.1. Russia Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Antiparasitic Drugs Market
- 23.1. North America Antiparasitic Drugs Market Overview
- 23.2. North America Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Antiparasitic Drugs Market
- 24.1. USA Antiparasitic Drugs Market Overview
- 24.2. USA Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Antiparasitic Drugs Market
- 25.1. Canada Antiparasitic Drugs Market Overview
- 25.2. Canada Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Antiparasitic Drugs Market
- 26.1. South America Antiparasitic Drugs Market Overview
- 26.2. South America Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Antiparasitic Drugs Market
- 27.1. Brazil Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Antiparasitic Drugs Market
- 28.1. Middle East Antiparasitic Drugs Market Overview
- 28.2. Middle East Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Antiparasitic Drugs Market
- 29.1. Africa Antiparasitic Drugs Market Overview
- 29.2. Africa Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Antiparasitic Drugs Market Competitive Landscape And Company Profiles
- 30.1. Antiparasitic Drugs Market Competitive Landscape
- 30.2. Antiparasitic Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Cadila Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co.Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
31. Antiparasitic Drugs Market Other Major And Innovative Companies
- 31.1. Novartis AG
- 31.2. Sanofi S.A.
- 31.3. GlaxoSmithKline plc
- 31.4. Takeda Pharmaceutical Company Limited
- 31.5. Boehringer Ingelheim group
- 31.6. Zoetis Inc.
- 31.7. Eisai Co. Ltd.
- 31.8. Covetrus Inc.
- 31.9. IDEXX Laboratories Inc.
- 31.10. Dr. Reddy's Laboratories
- 31.11. Intas Pharmaceuticals Ltd
- 31.12. Alkem Laboratories Ltd
- 31.13. Ceva Sante Animale S.A.
- 31.14. Elanco Animal Health Incorporated
- 31.15. Phibro Animal Health Corporation
32. Global Antiparasitic Drugs Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Antiparasitic Drugs Market
34. Recent Developments In The Antiparasitic Drugs Market
35. Antiparasitic Drugs Market High Potential Countries, Segments and Strategies
- 35.1 Antiparasitic Drugs Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Antiparasitic Drugs Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Antiparasitic Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
